Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cystic Fibrosis
Related studies linked through entity extraction aliases.
Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis
- Status
- TERMINATED
- Phase
- NA
Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Effects of a Partially Supervised Conditioning Program in CF
- Status
- COMPLETED
- Phase
- NA
Effect of Lactobacillus Reuteri in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE4
Time to Perform Lung Function Test in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- NA
Imaging Lung Function Using Oxygen Enhanced MRI
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Massage Therapy on QOL in Youth/Young Adults With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- NA
Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
- Status
- COMPLETED
- Phase
- PHASE1
Sweat Evaporimeter Measurement
- Status
- COMPLETED
- Phase
- NA
Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- NA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid in Cystic Fibrosis
- Status
- WITHDRAWN
- Phase
- PHASE4
Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
- Status
- TERMINATED
- Phase
- PHASE4